BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 3581480)

  • 1. Impairment of capping in lymphoblastoid cell lines of Duchenne patients indicates an intrinsic cellular defect.
    Baricordi OR; Sensi A; Balboni A; Romeo G; Rocchi M; Melchiorri L; Gandini E
    Hum Genet; 1989 Oct; 83(3):217-9. PubMed ID: 2793164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphocyte capping and the effect of lanthanum in Duchenne muscular dystrophy.
    Horenstein AL; Emery AE
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):303-12. PubMed ID: 6635321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capping of lymphocytes in patients and carriers of Duchenne muscular dystrophy.
    Ho AD; Stojakowits S; Reitter B; Fiehn W; Zipperle G; Hunstein W; Lipinski C
    Klin Wochenschr; 1980 Apr; 58(7):377-81. PubMed ID: 7392543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired HLA capping capacity of peripheral blood lymphocytes in Duchenne muscular dystrophy.
    Sensi A; Venturoli A; Traniello S; Lucci M; Vullo C; Conighi C; Mattiuz PL; BĂ„ricordi OR
    J Med Genet; 1984 Jun; 21(3):182-5. PubMed ID: 6379180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of lymphocyte capping in Duchenne muscular dystrophy.
    Nicholson GA; Sugars J
    J Neurol Sci; 1982 Mar; 53(3):511-8. PubMed ID: 7069446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blind evaluation of lymphocyte capping in Duchenne muscular dystrophy.
    Goldsmith BM; Drachman DB; Gruemer HD; Miller WG; Self SS
    Neurology; 1984 Jun; 34(6):821-4. PubMed ID: 6374498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic membrane defect and the inhibition of lymphocyte capping in Duchenne muscular dystrophy.
    Goldsmith BM; Gruemer HD
    Clin Chim Acta; 1987 Apr; 164(1):33-46. PubMed ID: 3581480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.